Alnylam Pharmaceuticals revenue

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Alnylam Pharmaceuticals revenue was $492.85 m in FY, 2020

	FY, 2010	FY, 2018	FY, 2019	FY, 2020
Revenue	$100.04 m	$74.91 m	$219.75 m	$492.85 m

	Q2, 2010	Q3, 2010	Q1, 2011	Q2, 2018	Q3, 2018	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020
Revenue	$26.62 m	$27.67 m	$20.9 m	$29.91 m	$2.07 m	$33.29 m	$44.71 m	$46.07 m	$99.48 m	$77.53 m	$99.21 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.